Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#HealthcareResearch

Home » #HealthcareResearch
CID’s Most-Read Article: “Miracle Drug” Metformin Significantly Reduces Viral Load in Outpatient COVID-19 Patients!

CID’s Most-Read Article: “Miracle Drug” Metformin Significantly Reduces Viral Load in Outpatient COVID-19 Patients!

Posted by By Mourabit Halima 2024.09.11
Editor's Note: Metformin, often hailed as a "miracle drug" for its wide range of therapeutic effects, was also considered a potential treatment for COVID-19 during the pandemic. Unfortunately, the large-scale…
Read More
JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management

JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management

Posted by By El Bachir MOURABIT 2024.09.10
Editor's Note: Metabolic-associated steatotic liver disease (MASLD) has become the fastest-growing cause of hepatocellular carcinoma (HCC). A recent multicenter clinical study led by Dr. Carole Vitellius from Angers University Hospital,…
Read More
AASLD Hot Updates on MASLD from the 2023 Annual Meeting

AASLD Hot Updates on MASLD from the 2023 Annual Meeting

Posted by By Kenzy Nour 2024.01.16
Editor's Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…
Read More
Recent Posts
  • World Hepatitis Day 2025 | Prof. George Lau: Exploring Optimal Strategies for HBV Antiviral Therapy from an Economic Perspective
  • APASL 2025 Expert Interview | Prof. George Lau: Dilemmas and Breakthroughs in Clinical Cure of Chronic Hepatitis B and Liver Cancer Prevention
  • China-Led International Real-World Study: TACE Plus Immunotherapy Boosts Survival Beyond 26 Months in Unresectable HCC
  • ILCA Roundtable | MDT: Optimizing HCC Treatment Strategies – Insights from the TALENT Series Studies
  • Prof. Qiang Wei: Gathering Global Expertise to Shape a New Landscape in Uro-Oncology at the West China Tianfu Academic Conference
Recent Comments
    Archives
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top